Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 107

Duolingo translates pitch to collect $10m

General Atlantic has supplied equity and secured shares through a secondary transaction, and will aid the CMU-founded language app developer's international growth objectives.

Apr 29, 2020

Corporates help cover Qoala's series A

The online insurance provider received $13.5m in a round led by Centauri Fund and backed by MassMutual Ventures, MDI Ventures and Central Capital Ventura.

Apr 29, 2020

InnovoPro invites Migros for $15m series B

The retail group returned to take part in a series B round that will find the expansion of chickpea-based protein developer InnovoPro's production capacity.

Apr 27, 2020

Corporate venturing deal net: 20-24 April 2020

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Apr 24, 2020

Leuven Instruments loops in series B financing

CAS Star has led a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.

Apr 24, 2020

Leuven Instruments loops in series B financing

Red Star Macalline was among the participants in a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.

Apr 24, 2020

Tridge tracks $11m for series B

Forest Partners and Activant Capital have invested $11m in the SoftBank-backed agriculture trading hub.

Apr 23, 2020

FoRx picks up $10m in seed round

M Ventures and Novartis Venture Fund co-led a round for the oncology drug startup that also featured fellow corporate venturing unit Pfizer Ventures.

Apr 23, 2020

H1 Insights pinpoints series A funding

Novartis DRX was among the investors in a $12.9m for the medical personnel database operator that lifted its overall funding close to $20m.

Apr 23, 2020

Phost’in bags $11.1m

Satt AxLR-allied Phost'in Therapeutics has secured funding to progress cancer drugs targeting glycosylation and the body's immune system.

Apr 23, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here